Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Psychosoc Oncol ; 34(4): 259-73, 2016.
Article in English | MEDLINE | ID: mdl-27355243

ABSTRACT

This study evaluated the psychobehavioral benefits of the Children's Lives Include Moments of Bravery (CLIMB®) intervention in 45 children (aged 6-11) with a parent/caregiver with cancer. Parent/caregiver reports of psychobehavioral functioning indicated signi-ficant decreases in children's emotional symptoms and marginally significant reductions in conduct problems. Child reports of emotion regulation indicated significant increases in emotion awareness, significant decreases in emotion suppression, and nonsignificant increases in emotion-focused coping and dysregulated expression. Parents/caregivers and children reported high satisfaction with CLIMB®. Results suggest CLIMB® is a promising intervention for improving psychobehavioral functioning and emotion regulation in children with a parent/caregiver with cancer.


Subject(s)
Child Behavior/psychology , Child of Impaired Parents/psychology , Emotions , Neoplasms , Adaptation, Psychological , Child , Child of Impaired Parents/statistics & numerical data , Female , Humans , Male , Pilot Projects , Program Evaluation
2.
Bioorg Med Chem ; 17(18): 6590-605, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19695884

ABSTRACT

Antagonists of the human A(2A) receptor have been reported to have potential therapeutic benefit in the alleviation of the symptoms associated with neurodegenerative movement disorders such as Parkinson's disease. As part of our efforts to discover potent and selective antagonists of this receptor, we herein describe the detailed optimization and structure-activity relationships of a series of pyrimidine-4-carboxamides. These optimized derivatives display desirable physiochemical and pharmacokinetic profiles, which have led to promising oral activity in clinically relevant models of Parkinson's disease.


Subject(s)
Adenosine A2 Receptor Antagonists , Parkinson Disease/drug therapy , Pyrimidines/chemistry , Pyrimidines/pharmacology , Receptor, Adenosine A2A/metabolism , Animals , Humans , Locomotion/drug effects , Mice , Protein Binding , Pyrimidines/pharmacokinetics , Pyrimidines/therapeutic use , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL